期刊文献+

注射用盐酸苯达莫司汀的制备及质量控制 被引量:1

Preparation and Quality Control of Bendamustine Hydrochloride for Injection
原文传递
导出
摘要 目的:制备注射用盐酸苯达莫司汀并建立其质量控制方法。方法:以冻干赋形剂甘露醇的不同用量为因素,以制剂的成形性等为指标筛选处方;确立制剂的制备工艺;采用高效液相色谱法测定制剂含量;根据2010年版《中国药典》相关要求考察制剂的鉴别、酸度、水分、有关物质和主药含量等质量控制指标。结果:选用2.25%甘露醇为辅料,制备时不采用脱炭工艺;成品各质量指标均符合《中国药典》相关要求。结论:所确定的制剂处方和制备工艺合理,所得产品质量可控。 OBJECTIVE: To prepare and control the quality of Bendamustine hydrochloride for injection. METHODS: The pre- scription was screened with the different amount of frozen-dried supporting agent mannitol as factor and compactibility of prepara- tion as index. The preparation technology was determined and HPLC method was adopted to determine the content of preparation. The identification, acid, moisture, the content of related substances and main components and other quality control index were in- vestigated according to Chinese Pharmacopoeia (2010 edition). RESULTS: 2.25% mannitol was used as excipient, and decarbon- ization technology wasn' t adopted. The quality index of products were all up to the requirements of Chinese Pharmacopoeia. CONCLUSION: The prescription and preparation technology is appropriate, and the quality of product is controllable.
出处 《中国药房》 CAS CSCD 2012年第13期1201-1203,共3页 China Pharmacy
关键词 注射用盐酸苯达莫司汀 制备 质量控制 Bendamustine hydrochloride for injection Preparation Quality control
  • 相关文献

参考文献4

  • 1Dreyling M.Bendamustine is a hybrid antimetabolite and alkylating agent offering new therapeutic options for the treatment of non-Hodgkin lymphomas[J].Hematology Meeting Reports,2008,2(5):123.
  • 2Tageja N,Nagi J.Bendamustine:something old,something new[J].Cancer Chemother Pharmacol,2010,66(3):413.
  • 3陈栋,宫平.盐酸苯达莫司汀[J].中国药物化学杂志,2009,19(2):159-160. 被引量:11
  • 4Gust G,Krauser R.Investigations on the stability of bendamustin,a cytostatic agent of the nitrogen mustard type,Ⅰ.synthesis,isolation,and characterization of reference substances[J].Monatshefte für Chemie Chemical Monthly,1997,128(3):291.

二级参考文献4

  • 1KRUEGER W, KRUEGER G. 4-[ 1-Methyl-5-bis [ (2-chloroethyl) amino ] - 2-benzimidazolyl ] butyric acid:DD, 159877 [ P]. 1983 - 04 - 13.
  • 2DREYLING M. Bendamusfine is a hybrid antimetabo- lite and alkylating agent offering new therapeutic op- tions for the treatment of non-Hodgkin lymphomas [ J]. Dreyling Hematology Meeting Reports, 2008,2 (5) :123 - 124.
  • 3BLUMEL S, GOODRICH A, MARTIN C. Bendarnustine:a novel cytotoxic agent for hematologic malignancies[J]. Clin J Oncol Nuts,2008,12(5) :799 - 806.
  • 4高丽梅,汪燕翔,宋丹青.盐酸苯达莫司汀的合成[J].中国新药杂志,2007,16(23):1960-1961. 被引量:14

共引文献10

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部